Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma
出版年份 2016 全文链接
标题
Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma
作者
关键词
Hilar cholangiocarcinoma, Carbohydrate antigen 19-9 (CA 19-9), Carbohydrate antigen 125 (CA 125), Resectability
出版物
SpringerPlus
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-04-30
DOI
10.1186/s40064-016-2181-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy
- (2015) Yu-Lei Gu et al. Asian Pacific Journal of Cancer Prevention
- Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma
- (2015) Junjie Xiong et al. JOURNAL OF SURGICAL RESEARCH
- Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
- (2015) Tao Chen et al. MEDICINE
- A New Clinically Based Staging System for Perihilar Cholangiocarcinoma
- (2014) Roongruedee Chaiteerakij et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer
- (2014) Liang Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma
- (2014) Erin G. Brown et al. JOURNAL OF SURGICAL ONCOLOGY
- Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma
- (2013) Rungsun Rerknimitr et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
- (2013) Guopei Luo et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Resection for Hilar Cholangiocarcinoma: Analysis of Prognostic Factors and the Impact of Systemic Inflammation on Long-term Outcome
- (2013) Traian Dumitrascu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV
- (2012) Q.-B. Cheng et al. EJSO
- Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
- (2012) Sarwa Darwish Murad et al. GASTROENTEROLOGY
- Surgical management of proximal bile duct cancers
- (2012) Jennifer LaFemina et al. LANGENBECKS ARCHIVES OF SURGERY
- Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival
- (2011) Akshat Saxena et al. AMERICAN JOURNAL OF SURGERY
- Analysis of the Surgical Outcome and Prognostic Factors for Hilar Cholangiocarcinoma: A Chinese Experience
- (2011) Huikai Li et al. DIGESTIVE SURGERY
- New staging system and a registry for perihilar cholangiocarcinoma
- (2011) Michelle L. DeOliveira et al. HEPATOLOGY
- Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
- (2010) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center
- (2010) Giorgio Ercolani et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience
- (2009) Sung Gyu Lee et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Surgery for hilar cholangiocarcinoma: The Leeds experience
- (2007) E. Hidalgo et al. EJSO
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now